SolasCure
PrivateLast Round
Accelerator
Jun 3, 2024
Total Funding Raised
$34.44M
Company Overview
SolasCure is a biotechnology company developing Aurase Wound Gel, a hydrogel-based therapeutic that uses a recombinant enzyme to debride chronic wounds and activate tissue repair.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SolasCure Comparables
Compare SolasCure with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ilya Pharma | 81% | |
| Mediwound Ltd | 78% | |
| Biotherapy Services | 76% | |
SolasCure Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Jun 3, 2024 | ||||
| Grant | Mar 20, 2024 | ||||
| Grant | Jun 1, 2023 | ||||
| Series B | Mar 27, 2023 | ||||
| Grant | Jan 11, 2023 | ||||
Series A | Oct 8, 2021 |
Key People
Founding team and executive leadership
SolasCure Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
| European Innovation Council Fund | Grant |
| Seneca Partners | Series A, Series B |
| Innovate UK | Accelerator, Grant |
| Texas Medical Center | Accelerator |
| Bionova Capital | Series A |
| Wealth Club | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 1, 2023
Received grant funding from the European Innovation Council.
- Mar 27, 2023
$13.3M round led by Seneca Partners.
SolasCure Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about SolasCure's valuation, stock price, and market status.